Policy | June 02, 2022
PMBI first time ever crossed Rs. 100 crore sales in May, 2022
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
68% of patients receiving Kymriah in the ELARA trial experienced a complete response, with an 86% overall response rate, along with a remarkable safety profile
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Manamed, a pioneering Medical Technology development company, has been granted FDA approval on its latest orthopaedic recovery device, ManaSport.
Subscribe To Our Newsletter & Stay Updated
